how many people in the us are on glp 1 GLP-1 use peaks middle age, then drops at 65 Gallup | More Americans are

Insulin and sulfonylureas can increase the chance of hypoglycemia when used as part of a diabetes plan

For my medullary patients the ones with the FDA warning I'm still saying, until we have better data, I can't recommend it

Our medical team uses a "lowest effective dose" model: We start every member at the lowest clinically appropriate dose We only escalate if progress stalls and all behavioral strategies have been exhausted We monitor for side effects continuously and reduce doses when appropriate A 2021 study in JAMA found that most patients regain lost weight within 12 months of stopping GLP-1s without behavioral support

Gastroparesis (also known as stomach paralysis) is a chronic disease that affects the nerves and muscles in the stomach, interfering with the muscle activity (peristalsis), making stomach muscle contractions slower and weaker, slowing the movement of food through the stomach and small intestine and causing food not to be properly processed or emptied

Applying it in the real world is where most lifters get stuck

The Humira biosimilar market finally emerged in 2023